{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:44:26Z","timestamp":1773287066346,"version":"3.50.1"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T00:00:00Z","timestamp":1592956800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0235248","type":"journal-article","created":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T13:39:21Z","timestamp":1593005961000},"page":"e0235248","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":58,"title":["Predictors of severe or lethal COVID-19, including Angiotensin Converting Enzyme inhibitors and Angiotensin II Receptor Blockers, in a sample of infected Italian citizens"],"prefix":"10.1371","volume":"15","author":[{"given":"Francesca","family":"Bravi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Elena","family":"Flacco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiziano","family":"Carradori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo Alberto","family":"Volta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Cosenza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aldo","family":"De Togni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4308-2144","authenticated-orcid":true,"given":"Cecilia","family":"Acuti Martellucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giustino","family":"Parruti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Mantovani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8129-9344","authenticated-orcid":true,"given":"Lamberto","family":"Manzoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,6,24]]},"reference":[{"key":"pone.0235248.ref001","unstructured":"COVID-19 Coronavirus Outbreak [Internet]. Dadax. 2020 [cited March 14, 2020]. Available from: https:\/\/www.worldometers.info\/coronavirus\/."},{"key":"pone.0235248.ref002","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","author":"X Yang","journal-title":"Lancet Respir Med"},{"key":"pone.0235248.ref003","article-title":"Clinical Characteristics of Coronavirus Disease 2019 in China.","author":"WJ Guan","year":"2020","journal-title":"The New England Journal of Medicine"},{"key":"pone.0235248.ref004","article-title":"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.","author":"JJ Zhang","year":"2020","journal-title":"Allergy"},{"issue":"2","key":"pone.0235248.ref005","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","volume":"181","author":"M Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"8","key":"pone.0235248.ref006","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury.","volume":"11","author":"K Kuba","year":"2005","journal-title":"Nat Med"},{"issue":"6965","key":"pone.0235248.ref007","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"W Li","year":"2003","journal-title":"Nature"},{"issue":"4","key":"pone.0235248.ref008","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.bbrc.2003.11.054","article-title":"The SARS-CoV S glycoprotein: expression and functional characterization","volume":"312","author":"X Xiao","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"pone.0235248.ref009","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/ajh\/hpu086","article-title":"Urinary angiotensin-converting enzyme 2 in hypertensive patients may be increased by olmesartan, an angiotensin II receptor blocker","volume":"28","author":"M Furuhashi","year":"2015","journal-title":"Am J Hypertens"},{"issue":"6","key":"pone.0235248.ref010","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/00004872-199606000-00017","article-title":"Effects of captopril related to increased levels of prostacyclin and angiotensin-(1\u20137) in essential hypertension.","volume":"14","author":"M Luque","year":"1996","journal-title":"J Hypertens"},{"issue":"14","key":"pone.0235248.ref011","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1161\/01.CIR.0000094734.67990.99","article-title":"Increased angiotensin-(1\u20137)-forming activity in failing human heart ventricles: evidence for upregulation of the angiotensin-converting enzyme Homologue ACE2.","volume":"108","author":"LS Zisman","year":"2003","journal-title":"Circulation"},{"issue":"20","key":"pone.0235248.ref012","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","volume":"111","author":"CM Ferrario","year":"2005","journal-title":"Circulation"},{"issue":"5","key":"pone.0235248.ref013","doi-asserted-by":"crossref","first-page":"C1169","DOI":"10.1152\/ajpcell.00145.2008","article-title":"MAP kinase\/phosphatase pathway mediates the regulation of ACE2 by angiotensin peptides","volume":"295","author":"PE Gallagher","year":"2008","journal-title":"Am J Physiol Cell Physiol"},{"issue":"3","key":"pone.0235248.ref014","doi-asserted-by":"crossref","first-page":"H1013","DOI":"10.1152\/ajpheart.00068.2005","article-title":"Angiotensin II AT1 receptors regulate ACE2 and angiotensin-(1\u20137) expression in the aorta of spontaneously hypertensive rats.","volume":"289","author":"M Igase","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"5","key":"pone.0235248.ref015","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1161\/01.HYP.0000124667.34652.1a","article-title":"Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors","volume":"43","author":"Y Ishiyama","year":"2004","journal-title":"Hypertension"},{"issue":"2","key":"pone.0235248.ref016","doi-asserted-by":"crossref","first-page":"F398","DOI":"10.1152\/ajprenal.90488.2008","article-title":"Localization of ACE2 in the renal vasculature: amplification by angiotensin II type 1 receptor blockade using telmisartan","volume":"296","author":"MJ Soler","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"pone.0235248.ref017","article-title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","author":"l Fang","year":"2020","journal-title":"Lancet Respir Med."},{"issue":"5","key":"pone.0235248.ref018","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/HJH.0000000000002450","article-title":"Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?","volume":"38","author":"M Esler","year":"2020","journal-title":"J Hypertens"},{"key":"pone.0235248.ref019","first-page":"m810","article-title":"Preventing a COVID-19 pandemic: ACE inhibitors as a potential risk factor for fatal COVID-19","volume":"368","author":"R Sommerstein","year":"2020","journal-title":"BMJ"},{"key":"pone.0235248.ref020","article-title":"Coronavirus Disease 2019 (COVID-19) Infection and Renin Angiotensin System Blockers.","author":"C Bavishi","year":"2020","journal-title":"JAMA Cardiol"},{"key":"pone.0235248.ref021","article-title":"COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: What Is the Evidence?","author":"AB Patel","year":"2020","journal-title":"JAMA"},{"key":"pone.0235248.ref022","doi-asserted-by":"crossref","first-page":"m1313","DOI":"10.1136\/bmj.m1313","article-title":"Drugs and the renin-angiotensin system in covid-19","volume":"369","author":"JK Aronson","year":"2020","journal-title":"BMJ"},{"key":"pone.0235248.ref023","article-title":"Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19","author":"M Vaduganathan","year":"2020","journal-title":"The New England Journal of Medicine"},{"key":"pone.0235248.ref024","article-title":"Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19","author":"P Zhang","year":"2020","journal-title":"Circ Res"},{"key":"pone.0235248.ref025","article-title":"Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China.","author":"J Li","year":"2020","journal-title":"JAMA Cardiol."},{"key":"pone.0235248.ref026","article-title":"Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19","author":"G Mancia","year":"2020","journal-title":"The New England Journal of Medicine"},{"key":"pone.0235248.ref027","article-title":"Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19).","author":"N Mehta","year":"2020","journal-title":"JAMA Cardiol."},{"key":"pone.0235248.ref028","article-title":"Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19","author":"HR Reynolds","year":"2020","journal-title":"The New England Journal of Medicine"},{"key":"pone.0235248.ref029","doi-asserted-by":"crossref","first-page":"m1198","DOI":"10.1136\/bmj.m1198","article-title":"Covid-19: risk factors for severe disease and death","volume":"368","author":"RE Jordan","year":"2020","journal-title":"BMJ"},{"key":"pone.0235248.ref030","article-title":"Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy.","author":"G Onder","year":"2020","journal-title":"JAMA"},{"key":"pone.0235248.ref031","article-title":"Features, Evaluation and Treatment Coronavirus (COVID-19).","author":"M Cascella","year":"2020"},{"issue":"3","key":"pone.0235248.ref032","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.3.2000045","article-title":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR.","volume":"25","author":"VM Corman","year":"2020","journal-title":"Euro Surveill"},{"key":"pone.0235248.ref033","unstructured":"World Health Organization. Laboratory testing for coronavirus disease (COVID-19) in suspected human cases\u2014Interim guidance. 2020 19 March 2020. Report No."},{"key":"pone.0235248.ref034","unstructured":"Italian Institute of Statistics (ISTAT). Aspects of daily life\u2014Health status\u2014Regions and Cities [Aspetti della vita quotidiana: Stato di salute\u2014regioni e tipo di comune]. In: Italian Institute of Statistics (ISTAT), editor. Rome2020."},{"key":"pone.0235248.ref035","article-title":"Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19","author":"M Vaduganathan","year":"2020","journal-title":"N Engl J Med"},{"key":"pone.0235248.ref036","article-title":"Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers","author":"AHJ Danser","year":"2020","journal-title":"Hypertension"},{"issue":"5","key":"pone.0235248.ref037","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41569-020-0360-5","article-title":"COVID-19 and the cardiovascular system.","volume":"17","author":"YY Zheng","year":"2020","journal-title":"Nat Rev Cardiol."},{"key":"pone.0235248.ref038","article-title":"Inhibitors of the Renin-Angiotensin-Aldosterone System and Covid-19","author":"JA Jarcho","year":"2020","journal-title":"N Engl J Med"},{"key":"pone.0235248.ref039","article-title":"Switching antihypertensive therapy in times of COVID-19: why we should wait for the evidence","author":"GM Kuster","year":"2020","journal-title":"European heart journal"},{"key":"pone.0235248.ref040","article-title":"SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?","author":"GM Kuster","year":"2020","journal-title":"European heart journal"},{"key":"pone.0235248.ref041","unstructured":"European Medicines A. EMA advises continued use of medicines for hypertension, heart or kidney disease during COVID-19 pandemic2020 April 20, 2020. Available from: https:\/\/www.ema.europa.eu\/en\/news\/ema-advises-continued-use-medicines-hypertension-heart-kidney-disease-during-covid-19-pandemic."},{"key":"pone.0235248.ref042","unstructured":"European Society of C. Position statement of the ESC Council on Hypertension on ACE-inhibitors and angiotensin receptor blockers.2020 April 20, 2020. Available from: https:\/\/www.escardio.org\/Councils\/Council-on-Hypertension-(CHT)\/News\/position-statement-of-the-esc-council-on-hypertension-on-ace-inhibitors-and-ang."},{"key":"pone.0235248.ref043","unstructured":"American Hearth A. Patients taking ACE-i and ARBs who contract COVID-19 should continue treatment, unless otherwise advised by their physician2020. Available from: https:\/\/newsroom.heart.org\/news\/patients-taking-ace-i-and-arbs-who-contract-covid-19-should-continue-treatment-unless-otherwise-advised-by-their-physician?utm_campaign=sciencenews19-20&utm_source=science-news&utm_medium=phd-link&utm_content=phd03-17-20."},{"key":"pone.0235248.ref044","article-title":"OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients [submitted].","author":"E Williamson","year":"2020","journal-title":"MedRxiv"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0235248","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T13:39:45Z","timestamp":1593005985000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0235248"}},"subtitle":[],"editor":[{"given":"Tatsuo","family":"Shimosawa","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,6,24]]},"references-count":44,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,6,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0235248","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.05.21.20109082","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,24]]}}}